Cannell & Co’s Biodesix BDSX Stock Holding History

Cannell & Co’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$378K	Hold	10,280	–	–	0.01%	222
2023 Q3	$339K	Hold	10,280	–	–	0.01%	216
2023 Q2	$253K	Hold	10,280	–	–	0.01%	235
2023 Q1	$382K	Hold	10,280	–	–	0.01%	220
2022 Q4	$473K	Hold	10,280	–	–	0.02%	206
2022 Q3	$261K	Hold	10,280	–	–	0.01%	231
2022 Q2	$337K	Hold	10,280	–	–	0.01%	229
2022 Q1	$347K	Hold	10,280	–	–	0.01%	244
2021 Q4	$1.09M	Hold	10,280	–	–	0.03%	177
2021 Q3	$1.69M	Hold	10,280	–	–	0.05%	154
2021 Q2	$2.72M	Buy	+10,280	New	+$3.23M	0.08%	134

Other funds holding BDSX

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Cannell & Co's BDSX Position: Q4 2023 in Review

Cannell & Co held its Biodesix (BDSX) position steady in Q4 2023 at 10,280 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #222.

Cannell & Co first reported a position in BDSX in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.72M in Q2 2021. 38 funds tracked by Wall St. Rank hold BDSX as of Q4 2023.

Cannell & Co held 10,280 shares of Biodesix worth $378K as of Q4 2023.
Cannell & Co left its Biodesix share count unchanged in Q4 2023.
Biodesix made up 0.01% of Cannell & Co's portfolio in Q4 2023, its #222 holding.
Cannell & Co first reported a position in Biodesix in Q2 2021 and has held it in 11 quarters since.
Cannell & Co's Biodesix position peaked at $2.72M in Q2 2021.
38 funds tracked by Wall St. Rank held Biodesix as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.